Hanada et al. reported that the combination of ASNS knockout and ASNase inhibits the growth of KRAS-mutant CRC cells, and that the combination therapy of asparagine depletion and macropinocytosis inhibition dramatically suppresses tumor growth of KRAS-mutant CRC cells [64]. The gene discussed is KRAS; the disease is colorectal carcinoma.